Talk:Lymphotoxin alpha

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Untitled

Hi,

These are the following sources I will be using to discuss and further elaborate on the topic of lymphotoxin alpha for the time being:

Background information about lymphotoxin:

"Lymphotoxin and TNF: How it all began-A tribute to the travelers"

Roles of LT-alpha as an immune regulator:

"Tumor necrosis factor and lymphotoxin in regulation of intestinal inflammation"

"TNF and Lymphotoxin in immune regulation and cancer"

"Dendritic cell regulation of NK-cell responses involves lymphotoxin-, IL-12, and TGF-"

"Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy"

Sarhan D, Palma M, Mao Y, Adamson L, Kiessling R, Mellstedt H, et al. (June 2015). "Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β". European Journal of Immunology. 45 (6): 1783–93. doi:10.1002/eji.201444885. PMID 25773885.
Drutskaya M, Atretkhany KS, Zvartsev R, Kruglov A, Nedospasov S (July 2015). "TNF and Lymphotoxin in immune regulation and cancer". FEBS Journal. 282 (SI): 35.
Gubernatorova EO, Tumanov AV (November 2016). "Tumor Necrosis Factor and Lymphotoxin in Regulation of Intestinal Inflammation". Biochemistry. Biokhimiia. 81 (11): 1309–1325. doi:10.1134/S0006297916110092. PMID 27914457.
Ruddle NH (April 2014). "Lymphotoxin and TNF: how it all began-a tribute to the travelers". Cytokine & Growth Factor Reviews. 25 (2): 83–9. doi:10.1016/j.cytogfr.2014.02.001. PMID 24636534.
Lukashev M, LePage D, Wilson C, Bailly V, Garber E, Lukashin A, et al. (October 2006). "Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy". Cancer Research. 66 (19): 9617–24. doi:10.1158/0008-5472.CAN-06-0217. PMID 17018619.

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Immcarle35.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 10:44, 18 January 2022 (UTC)[reply]

Talk:Lymphotoxin alpha

Untitled

Wiki Education Foundation-supported course assignment

Navigation menu

Search